Evidence map›Paper›PMID 26480812›Full record

ArticleNeuroscience2015

Alcohol and high fat induced chronic pancreatitis: TRPV4 antagonist reduces hypersensitivity.

L P Zhang, R H Kline, G Deevska, F Ma, M Nikolova-Karakashian, K N Westlund

Abstract read
In one paragraph

Article in Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Novel and Experimental Therapies in Chronic Pancreatitis.Digestive diseases and sciences · 2017
    Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

L P ZhangDepartment of Physiology, College of Medicine, University of Kentucky, Lexington, KY 40526-0298, United States.
R H KlineDepartment of Physiology, College of Medicine, University of Kentucky, Lexington, KY 40526-0298, United States.
G DeevskaDepartment of Physiology, College of Medicine, University of Kentucky, Lexington, KY 40526-0298, United States.
F MaDepartment of Physiology, College of Medicine, University of Kentucky, Lexington, KY 40526-0298, United States.
M Nikolova-KarakashianDepartment of Physiology, College of Medicine, University of Kentucky, Lexington, KY 40526-0298, United States.
K N WestlundDepartment of Physiology, College of Medicine, University of Kentucky, Lexington, KY 40526-0298, United States. Electronic address: kwhigh2@uky.edu.
University of Kentucky · US

Funding

The Interaction of Interleukin 1b and Glucocorticoid Signaling Pathways in Alzheimer's DiseaseR01AG019223 · NIA · UNIVERSITY OF KENTUCKY · PI NIKOLOVA-KARAKASHIAN, MARIANA N · 2002 to 2022
$5.1M
NEUROGENIC AMPLIFICATION OF PANCREATITIS PAINR01NS039041 · NINDS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI WESTLUND-HIGH, KARIN N. · 2000 to 2014
$4.8M
Role of Neutral Sphingomyelinase-2 in agingR01AG026711 · NIA · UNIVERSITY OF KENTUCKY · PI NIKOLOVA-KARAKASHIAN, MARIANA N · 2007 to 2011
$1.4M
NIA NIH HHS 2R01 AG019223NIA NIH HHS R01 AG019223NIA NIH HHS R01 AG026711NINDS NIH HHS R01 5NS039041NINDS NIH HHS R01 NS039041
6 · The paper itself

Abstract

The pathogenesis of pain in chronic pancreatitis is poorly understood, and its treatment can be a major clinical challenge. Surgical and other invasive methods have variable outcomes that can be unsatisfactory. Therefore, there is a great need for further discovery of the pathogenesis of pancreatitis pain and new therapeutic targets. Human and animal studies indicate a critical role for oxidative stress and activation of transient receptor potential (TRP) cation channel subfamily members TRPV1 and TRPA1 on pancreatic nociceptors in sensitization mechanisms that result in pain. However, the in vivo role of transient receptor potential cation channel subfamily V member 4 (TRPV4) in chronic pancreatitis needs further evaluation. The present study characterized a rat alcohol/high fat diet (AHF)-induced chronic pancreatitis model with hypersensitivity, fibrotic pathology, and fat vacuolization consistent with the clinical syndrome. The rats with AHF-induced pancreatitis develop referred visceral pain-like behaviors, i.e. decreased hindpaw mechanical thresholds and shortened abdominal and hindpaw withdrawal latency to heat. In this study, oxidative stress was characterized as well as the role of TRPV4 in chronic visceral hypersensitivity. Lipid peroxidase and oxidative stress were indicated by increased plasma thiobarbituric acid reactive substances (TBARS) and diminished pancreatic manganese superoxide dismutase (MnSOD). The secondary sensitization associated with AHF-induced pancreatitis was effectively alleviated by the TRPV4 antagonist, HC 067047. Similarity of the results to those with the peripherally restricted μ-opiate receptor agonist, loperamide, suggested TRPV4 channel activated peripheral sensitization. This study using a reliable model that provides pre-clinical correlates of human chronic pancreatitis provides further evidence that TRPV4 channel is a potential therapeutic target for treatment of pancreatitis pain.

Indexed as

AnalgesicsAnimalsDiet, High-FatDisease Models, AnimalDrug Evaluation, PreclinicalEthanolHot TemperatureLoperamideMaleMorpholinesOxidative StressPainPain ThresholdPancreatitis, ChronicPyrrolesRandom AllocationAnalgesicsEthanolHC-067047LoperamideMorpholinesPyrrolesReceptors, Opioid, muTrpv4 protein, ratTRPV Cation ChannelsbehaviorHC 067047loperamideratTBARSvisceral pain

Identifiers

PMID26480812
PMCPMC4670827
OpenAlexW1774871198

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.